JPS538708B2 - - Google Patents

Info

Publication number
JPS538708B2
JPS538708B2 JP484075A JP484075A JPS538708B2 JP S538708 B2 JPS538708 B2 JP S538708B2 JP 484075 A JP484075 A JP 484075A JP 484075 A JP484075 A JP 484075A JP S538708 B2 JPS538708 B2 JP S538708B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP484075A
Other languages
Japanese (ja)
Other versions
JPS50100066A (en:Method
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS50100066A publication Critical patent/JPS50100066A/ja
Publication of JPS538708B2 publication Critical patent/JPS538708B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP484075A 1974-01-09 1975-01-08 Expired JPS538708B2 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB95974A GB1438092A (en) 1974-01-09 1974-01-09 Benzene-sulphonamides and processes for their preparation

Publications (2)

Publication Number Publication Date
JPS50100066A JPS50100066A (en:Method) 1975-08-08
JPS538708B2 true JPS538708B2 (en:Method) 1978-03-31

Family

ID=9713512

Family Applications (1)

Application Number Title Priority Date Filing Date
JP484075A Expired JPS538708B2 (en:Method) 1974-01-09 1975-01-08

Country Status (10)

Country Link
US (1) US4048313A (en:Method)
JP (1) JPS538708B2 (en:Method)
BE (1) BE824198A (en:Method)
CA (1) CA1064489A (en:Method)
CH (1) CH591466A5 (en:Method)
DE (1) DE2500499A1 (en:Method)
FR (1) FR2256759B1 (en:Method)
GB (1) GB1438092A (en:Method)
NL (1) NL160265C (en:Method)
ZA (1) ZA75150B (en:Method)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3922387A1 (de) * 1989-07-07 1991-01-17 Kali Chemie Pharma Gmbh N-benzyl-n-((1s,5s)-6,6-dimethylbicyclo/3.1.1/hept-2-ylaethoxy-aethyl)-morpholinium-salze enthaltende gastroprotektiv wirksame pharmazeutische zubereitungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896124A (en) * 1971-07-07 1975-07-22 Pfizer Preparation of 2 (aryl)-as-triazine-3,5(2h,4h)-diones

Also Published As

Publication number Publication date
CH591466A5 (en:Method) 1977-09-15
JPS50100066A (en:Method) 1975-08-08
AU7717175A (en) 1976-07-08
FR2256759B1 (en:Method) 1978-07-28
NL7500190A (nl) 1975-07-11
CA1064489A (fr) 1979-10-16
ZA75150B (en) 1976-01-28
US4048313A (en) 1977-09-13
BE824198A (fr) 1975-07-08
GB1438092A (en) 1976-06-03
DE2500499A1 (de) 1975-07-10
NL160265B (nl) 1979-05-15
FR2256759A1 (en:Method) 1975-08-01
NL160265C (nl) 1979-10-15

Similar Documents

Publication Publication Date Title
FI750430A7 (en:Method)
JPS50100066A (en:Method)
AU495870B2 (en:Method)
FI117474A7 (en:Method)
AR203034Q (en:Method)
AU8476175A (en:Method)
AU7478474A (en:Method)
AU7470174A (en:Method)
AU7253374A (en:Method)
CS174466B1 (en:Method)
DK120775A (en:Method)
DK38574A (en:Method)
BG19721A1 (en:Method)
BG19967A1 (en:Method)
AU482294A (en:Method)
BG20143A1 (en:Method)
AU479624A (en:Method)
BG19995A1 (en:Method)
DD115088A5 (en:Method)
BG19713A1 (en:Method)
AU480902A (en:Method)
BG19872A1 (en:Method)
BG20045A1 (en:Method)
AU479448A (en:Method)
BG19896A1 (en:Method)